ERD

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

01-05-2023

-

30-04-2026

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

MyPeBS | International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70

01-01-2018

-

30-06-2026

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

01-01-2017

-

31-12-2023

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

AECC Talent | FCAECC Fellowship programme for talented researchers in cancer

01-09-2023

-

31-08-2028

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

EUonQoL | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

01-01-2023

-

31-12-2026

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

e-QuoL | e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia

01-01-2024

-

31-12-2027

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

MONALISA | A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

01-01-2024

-

31-12-2028

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

CGI-Clinics | Data-driven cancer genome interpretation for personalised cancer treatment

01-11-2022

-

31-10-2027

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

T-RAFIC | Training network for tracking and controlling therapeutic immune cells in cancer

01-04-2025

-

31-03-2029

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

VIDA | VHIO International postDoctoral programme for translAtional research

01-01-2025

-

31-12-2029

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

ALKATRAS | ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer

01-09-2015

-

31-08-2019

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.

01-01-2019

-

30-06-2025

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

ThermoBreast | An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring

01-01-2023

-

31-12-2026

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

STRONG-AYA | THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER

01-10-2022

-

30-09-2027

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

IHMCSA | International Human Microbiome Coordination and Support Action

01-05-2021

-

30-04-2024

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma.

01-12-2017

-

31-05-2022

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

01-04-2023

-

31-03-2028

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

CARE1 | First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

01-05-2023

-

30-04-2028

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

HIT-GLIO | Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy

01-12-2023

-

30-11-2027

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

CCE_DART | Building Data Rich Clinical Trials

01-02-2021

-

31-01-2025

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

PREVALUNG EU | Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception.

01-12-2022

-

30-11-2027

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

SALVOVAR | A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES

01-05-2023

-

30-04-2028

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

RealCare | Real-time biomarker detection systems for rapid medical decision-making in cancer and cardiac diseases

01-12-2023

-

30-11-2028

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

NeutroCure | Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.

01-01-2020

-

31-12-2024

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

4-IN THE LUNG RUN | 4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening

01-01-2020

-

31-12-2024

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

IMMUTRAIN | Training Network for the Immunotherapy of Cancer

01-12-2015

-

30-11-2019

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

TREL | Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania

01-01-2021

-

31-12-2023

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

TREATLIVMETS | Treating Liver Metastasis

01-07-2024

-

30-06-2030

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

SilkFUSION | Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research

01-11-2017

-

31-10-2022

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

SilkPlatelet | Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactor

01-10-2022

-

30-09-2025

Show more information

Organisation INSTITUT GUSTAVE ROUSSY

Projects overview

Selected filters:

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

MyPeBS | International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70

ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

AECC Talent | FCAECC Fellowship programme for talented researchers in cancer

EUonQoL | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

e-QuoL | e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia

MONALISA | A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

CGI-Clinics | Data-driven cancer genome interpretation for personalised cancer treatment

T-RAFIC | Training network for tracking and controlling therapeutic immune cells in cancer

VIDA | VHIO International postDoctoral programme for translAtional research

ALKATRAS | ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer

ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.

ThermoBreast | An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring

STRONG-AYA | THE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER

IHMCSA | International Human Microbiome Coordination and Support Action

CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma.

PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

CARE1 | First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

HIT-GLIO | Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy

CCE_DART | Building Data Rich Clinical Trials

PREVALUNG EU | Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception.

SALVOVAR | A EUROPEAN MULTI-DISCIPLINARY CLINICAL PROJECT MEANT TO IMPROVE THE MANAGEMENT OF PATIENTS WITH POOR PROGNOSTIC OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY: RESTORING HOPE, SALVAGING LIVES

RealCare | Real-time biomarker detection systems for rapid medical decision-making in cancer and cardiac diseases

NeutroCure | Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation.

4-IN THE LUNG RUN | 4-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening

IMMUTRAIN | Training Network for the Immunotherapy of Cancer

TREL | Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania

TREATLIVMETS | Treating Liver Metastasis

SilkFUSION | Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research

SilkPlatelet | Closing the European gap towards a large scale ex vivo platelet production built upon a silk-based scaffold bioreactor